scholarly journals The Labcor Stentless Valved Pulmonary Conduit for RVOT Reconstruction: A 7-Year Experience

2018 ◽  
Vol 66 (S 01) ◽  
pp. S1-S110
Author(s):  
J. Jussli-Melchers ◽  
J. Steer ◽  
C. Grothusen ◽  
J. Logoteta ◽  
J.-H. Hansen ◽  
...  
Keyword(s):  
2013 ◽  
Vol 9 (6) ◽  
pp. 768-768 ◽  
Author(s):  
Jan Harnek ◽  
Peter Hochbergs ◽  
Ulf Thilen ◽  
Johan Holm ◽  
Henrik Bjursten ◽  
...  

2013 ◽  
Vol 96 (5) ◽  
pp. 1695-1702 ◽  
Author(s):  
Jeffrey A. Poynter ◽  
Pirooz Eghtesady ◽  
Brian W. McCrindle ◽  
Henry L. Walters ◽  
Paul M. Kirshbom ◽  
...  

2009 ◽  
Vol 17 (4) ◽  
pp. 350-356 ◽  
Author(s):  
Gláucio Furlanetto ◽  
Carlos H Passerino ◽  
Rolland Siegel ◽  
David T Chueng ◽  
Sidney Levitsky ◽  
...  

As there is currently no suitable valved pulmonary conduit for small children, porcine conduits treated by the L-Hydro process were implanted into 9 newborn lambs to investigate growth potential. Of the 8 survivors, 7 were kept alive for 12 months after implantation. The diameter of the conduit and gradient across the valve were evaluated at surgery and at 3 and 9 months postoperatively using bidirectional echocardiographic and angiographic methods. After sacrifice, histological and radiological analyses were performed. The mean weight of the animals was 4.2 ± 1.1 kg at implantation and 43.1 ± 6.2 kg at sacrifice. There was a significant increase in mean valve area from 139.9 ± 18.0 mm2 at implantation to 443.5 ± 89.2 mm2 at 12 months. Pre-sacrifice angiography showed no transvalvular gradient, and radiographic analysis did not reveal significant conduit wall or leaflet calcification in any of the animals. Histological examination of the grafts demonstrated total integration, with native-like intact valve leaflets. Thus functional evaluation, echocardiography, and histology demonstrated growth of the grafts with completely endothelialized and apparently normal pulmonary valve leaflets without calcification.


1997 ◽  
Vol 272 (1) ◽  
pp. L51-L59 ◽  
Author(s):  
T. Stevens ◽  
B. Fouty ◽  
L. Hepler ◽  
D. Richardson ◽  
G. Brough ◽  
...  

Pulmonary microvascular endothelium forms a tighter barrier than does pulmonary artery endothelium; the mechanism of this important phenotypic difference is uncertain. We examined two regulators of endothelial permeability, cytosolic Ca2+ concentration ([Ca2+]i) and adenosine 3',5'-cyclic monophosphate (cAMP), in microvascular (PMVEC) and pulmonary conduit artery (PAEC) endothelium. Both resting and stimulated [Ca2+]i were lower in PMVEC compared with PAEC (resting [Ca2+]i, 94 +/- 7 vs. 123 +/- 8 nM; ATP-stimulated peak, 1.04 +/- 0.14 vs. 1.98 +/- 0.13 microM). Sustained Ca2+ transients in response to either ATP or thapsigargin were reduced in PMVEC compared with PAEC (ATP, 199 +/- 22 vs. 411 +/- 43 nM; thapsigargin, 195 +/- 13 vs. 527 +/- 65 nM), suggesting reduced Ca2+ influx in PMVEC. Reduced Ca2+ influx in PMVEC was confirmed by Mn2+ quenching and patch-clamp experiments. mRNA for Ca(2+)-inhibitable and protein kinase C-stimulated adenylyl cyclases was detected in both cell types. Whereas ATP caused a [Ca2+]i-mediated decrease in cAMP in PAEC, ATP caused a protein kinase C-mediated increase in cAMP in PMVEC. We conclude that PMVEC express a unique phenotype that favors enhanced barrier function through attenuated Ca2+ influx and preservation of cAMP content.


2009 ◽  
Vol 36 (3) ◽  
pp. 595-597 ◽  
Author(s):  
Enrico Ferrari ◽  
Christopher Sulzer ◽  
Elena Rizzo ◽  
Ludwig Karl von Segesser

2014 ◽  
Vol 32 (2) ◽  
pp. 361-364 ◽  
Author(s):  
John C. Gulotta ◽  
Saurabh Gaba ◽  
Serkan Bulur ◽  
Marisa Joson ◽  
Aylin Sungur ◽  
...  

Author(s):  
Anno Diegeler ◽  
Stefan Fröhner ◽  
Ingo Dähnert

Stenting of the Shelhigh pulmonary conduit was performed 2 years after a Ross procedure because of a stenosis of the distal segment. We used the new Siemens Artis Zeego technology. A precise placement of the stent to release the stenosis within the distal segment simultaneously retaining a competent valve was possible by using the Dyna-computed tomography technology. The early onset of a stenosis of the Shelhigh xenograft in the pulmonary position is alarming, thus, its use can not be recommended for a replacement of the pulmonary valve.


Sign in / Sign up

Export Citation Format

Share Document